Clocinnamox
From Wikipedia, the free encyclopedia
 |
|
| Names | |
|---|---|
| IUPAC name
(E)-N-[(4R,4aS,7aR,12bR)-3-(Cyclopropylmethyl)-9-hydroxy-7-oxo-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a-yl]-3-(4-chlorophenyl)prop-2-enamide
|
|
| Other names
Chlorocinnamoylaminodihydronormorphinone
|
|
| Identifiers | |
| ChEMBL | ChEMBL386492 |
| ChemSpider | 5022878 |
| Jmol 3D model | Interactive image |
| PubChem | 6540640 |
|
|
|
|
| Properties | |
| C29H29ClN2O4 | |
| Molar mass | 505.01 g·mol−1 |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
| Infobox references | |
Clocinnamox is a selective, irreversible μ-opioid receptor antagonist.[1]
References[edit]
- ^ Filho, CB; Del Fabbro, L; De Gomes, MG; Goes, AT; Souza, LC; Boeira, SP; Jesse, CR (2013). "Kappa-opioid receptors mediate the antidepressant-like activity of hesperidin in the mouse forced swimming test". European Journal of Pharmacology. 698 (1–3): 286–91. doi:10.1016/j.ejphar.2012.11.003. PMID 23178563.
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
